Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase II trial studies of Genasense in combination with rituximab/fludarabine for CLL

Aug. 1, 2003

Aventis and ImmunoGen combine forces to develop anticancer therapeutics

Aug. 1, 2003

Human breast cancer growth inhibited by nocturnal melatonin

July 31, 2003

Evidence of antitumor effects of DMXAA in refractory solid tumors

July 31, 2003

Additive antitumor effects described for SU-5416 and dalteparin in a glioblastoma cell line

July 31, 2003

Feasibility of PACT approach to solid tumor therapy demonstrated using CVS-10290

July 30, 2003

Potential chemopreventive agents in development at SRI

July 30, 2003

Telomerase inhibitor GRN-163 advances through preclinical testing

July 29, 2003

Potent and selective antitumor activity demonstrated for anti-CD30 antibody-drug conjugate

July 29, 2003

PEG-camptothecin advances for gastric and gastroesophageal junction cancers

July 29, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...